Angitia Incorporated Limited
Clinical trials sponsored by Angitia Incorporated Limited, explained in plain language.
-
New shot aims to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study tests a drug called AGA2115 in 80 adults with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. Participants receive either the drug or a placebo as a shot under the skin. The main goal is to see if the drug increases bone density in the spine after 1…
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug AGA2118 tested in healthy volunteers across ethnic groups
Knowledge-focused Recruiting nowThis early-stage study is testing a single dose of a drug called AGA2118 in 30 healthy adults of Japanese, Chinese, and Caucasian backgrounds. Researchers want to see how the drug moves through the body and if it causes any side effects. The goal is to gather basic safety and dos…
Phase: PHASE1 • Sponsor: Angitia Incorporated Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC